Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis

dc.contributor.author	Broséus, Julien
dc.contributor.author	Alpermann, T.
dc.contributor.author	Wulfert, M.
dc.contributor.author	Brichs, L. F.
dc.contributor.author	Jeromin, S.
dc.contributor.author	Lippert, E.
dc.contributor.author	Rozman, M.
dc.contributor.author	Lifermann, F.
dc.contributor.author	Grossmann, V.
dc.contributor.author	Luño Fernández, Elisa
dc.date.accessioned	2013-05-07T07:46:01Z
dc.date.available	2013-05-07T07:46:01Z
dc.date.issued	2013-04
dc.identifier.citation	Leukemia, 27(9), p. 1826-1831(2013); doi:10.1038/leu.2013.120
dc.identifier.issn	0887-6924
dc.identifier.issn	1476-5551
dc.identifier.uri	http://hdl.handle.net/10651/14544
dc.description.statementofresponsibility	Broséus, J., Alpermann, T., Wulfert, M., Florensa Brichs, L., Jeromin, S., Lippert, E., Rozman, M., Lifermann, F., Grossmann, V., Haferlach, T., Germing, U., Luño, E., Girodon, F., Schnittger, S.
dc.format.extent	p. 1826-1831
dc.language.iso	eng
dc.relation.ispartof	Leukemia	spa
dc.rights	© 2013 Macmillan Publishers Limited
dc.title	Age, JAK2V617F and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis	spa
dc.type	journal article
dc.identifier.doi	10.1038/leu.2013.120
dc.relation.publisherversion	http://dx.doi.org/10.1038/leu.2013.120
dc.rights.accessRights	open access